National Academies Press: OpenBook

The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies (2013)

Chapter: Appendix E: Agendas of Public Meetings Held by the Committee

« Previous: Appendix D: Study Designs for the Safety Evaluation of Different Childhood Immunization Schedules--Martin Kulldorff
Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×

Appendix E

Agendas of Public Meetings Held by the Committee

February 9, 2012
The Pew Charitable Trusts
901 E Street, NW
Washington, DC 20004

Welcome and Overview

Ada Sue Hinshaw, Ph.D., R.N.

Committee Chair

Presentation of the Charge from the National Vaccine Program Office

Bruce Gellin, M.D., M.P.H.

Deputy Assistant Secretary for Health

Director, National Vaccine Program Office, U.S. Department of Health and Human Services

Review of the IOM Committee to Review Adverse Effects of Vaccines

Ellen Wright Clayton, J.D., M.D.

Chair of the IOM Committee to Review Adverse Effects of Vaccines

Craig-Weaver Professor of Pediatrics, Vanderbilt University

National Vaccine Information Center Perspectives

Barbara Loe Fisher

Co-Founder and President, National Vaccine Information Center

Provider Perspectives

Gary Freed, M.D., M.P.H.

Professor, Department of Health Management and Policy, University of Michigan School of Public Health

Director, Division of General Pediatrics

The Percy and Mary Murphy Professor of Pediatrics and Child Health Delivery

Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×

The Use of Clinical Trials for Childhood Vaccines

Susan Ellenberg, Ph.D.

Professor of Biostatistics and Associate Dean for Clinical Research

Perelman School of Medicine at the University of Pennsylvania

Ethical Issues in Clinical Trials

Robert (Skip) Nelson, M.D., Ph.D.

Senior Pediatric Ethicist/Lead Medical Officer, Food and Drug Administration

National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC)

Melinda Wharton, M.D., M.P.H.

Deputy Director, NCIRD, CDC

Captain, U.S. Public Health Service

Immunization Safety Office (ISO), CDC

Frank DeStefano, M.D., M.P.H.

Director, ISO, CDC

Data and Approaches in National and International Immunization Studies

Saad Omer, Ph.D., M.P.H., M.B.B.S.

Assistant Professor, Hubert Department of Global Health Epidemiology, Emory University Rollins School of Public Health

Assistant Professor, Emory Vaccine Center

Immune Profiling Research

Chuck Hackett, Ph.D.

Deputy Director, Division of Allergy, Immunology, and Transplantation

National Institute of Allergy and Infectious Diseases

OPEN SESSION—Opportunity for Attendee Comments

Adjourn

Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×

March 8, 2012
Talaris Conference Center
4000 NE 41st Street
Seattle, WA 98105

Welcome and Overview

Ada Sue Hinshaw, Ph.D., R.N.

Committee Chair

Welcome from Washington State Department of Health

Mary Selecky

Secretary of Health, Washington State Department of Health

Maxine Hayes, M.D., M.P.H.

State Health Officer, Washington State Department of Health

Washington State’s Immunization Programs

Janna Bardi, M.P.H.

Office Director, Immunization and Child Profile Office

Washington State Department of Health

Findings on Alternative Immunization Schedule Practices

Douglas Opel, M.D., M.P.H.

Assistant Professor of Pediatrics, Adjunct Assistant Professor of Bioethics and Humanities

University of Washington

Treuman Katz Center for Pediatric Bioethics

Seattle Children’s Research Institute

Assessing the Safety of Vaccines at the FDA: Pre- and Postlicensure Evaluations

Marion F. Gruber, Ph.D. (by phone)

Acting Director, Office of Vaccines Research and Review

Center for Biologics Evaluation and Research

Office of Medical Products and Tobacco

Food and Drug Administration

Karen Farizo, M.D. (by phone)

Acting Associate Director for Medical Policy and Safety

Office of Vaccines Research and Review

Center for Biologics Evaluation and Research

Office of Medical Products and Tobacco

Food and Drug Administration

Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×

Issues Leading to Vaccine Hesitancy

Douglas Opel, M.D., M.P.H.

Assistant Professor of Pediatrics, Adjunct Assistant Professor of Bioethics and Humanities

University of Washington

Treuman Katz Center for Pediatric Bioethics

Seattle Children’s Research Institute

Process for Immunization Schedule Recommendations

Edgar Marcuse, M.D., M.P.H.

Professor of Pediatrics, Adjunct Professor of Epidemiology, University of Washington

Associate Medical Director, Quality Improvement, Seattle Children’s Hospital

Decision Making at Advisory Committee on Immunization Practices in Response to Unanticipated Adverse Event Detection

Jeffrey Duchin, M.D.

Chief, Communicable Disease Epidemiology and Immunization Section

Public Health

Seattle and King County, Washington

Provider Self-Efficacy and Tools to Improve Immunization Rates

David Grossman, M.D., M.P.H.

Medical Director, Preventive Care

Group Health Cooperative

Group Health Research Institute and the Vaccine Safety Datalink

Michael L. Jackson, Ph.D., M.P.H.

Assistant Scientific Investigator

Group Health Research Institute

OPEN SESSION—Opportunity for Attendee Comments

Adjourn

Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×

May 29, 2012
The Pew Charitable Trusts
901 E Street, NW
Washington, DC 20004

Welcome and Overview

Ada Sue Hinshaw, Ph.D., R.N.

Committee Chair

U.S. Childhood Immunization Schedule Decisions

Margaret B. Rennels, M.D.

Professor of Pediatrics, University of Maryland School of Medicine (retired)

Independent Consultant

Question and Answer

Vaccine Policy and Safety Surveillance in the United Kingdom

Elizabeth Miller (by phone)

Head, Immunization Division

Communicable Disease Surveillance Centre

Health Protection Agency, Colindale, United Kingdom

Question and Answer

Vaccine Decisions: Policy Making and Priority Setting in Canada

Charlotte Moore Hepburn, M.D., F.R.C.P.C., F.A.A.P.

Lead, Child Health Policy Initiative

Assistant Professor, University of Toronto School of Medicine

Staff Paediatrician, Division of Paediatric Medicine, The Hospital for Sick Children

Question and Answer

Advisory Committee on Immunization Practices Decision Making

Melinda Wharton, M.D., M.P.H.

Deputy Director, National Center for Immunization and Respiratory Diseases

Centers for Disease Control and Prevention

Captain, U.S. Public Health Service

Question and Answer

Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×

Alternative Immunization Schedules: A Feasibility Study for Evaluating Vaccine Safety and the Risk of Pertussis

Jason Glanz, Ph.D.

Epidemiologist, Institute for Health Research

Kaiser Permanente Colorado

Question and Answer

Study Designs for the Safety Evaluation of Different Childhood Immunization Schedules

Martin Kulldorff, Ph.D.

Professor, Biostatistician, Department of Population Medicine Harvard

Medical School and Harvard Pilgrim Health Care Institute

Question and Answer

Commentary on Commissioned Paper and Other Committee Considerations

Michael A. Stoto, Ph.D.

Professor of Health Systems Administration and Population Health

Georgetown University School of Nursing and Health Studies

Question and Answer

OPEN SESSION—Opportunity for Attendee Comments

Adjourn

Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 201
Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 202
Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 203
Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 204
Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 205
Suggested Citation:"Appendix E: Agendas of Public Meetings Held by the Committee." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 206
Next: Appendix F: Biographical Sketches of Committee Members »
The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies Get This Book
×
Buy Paperback | $47.00 Buy Ebook | $37.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Vaccines are among the most safe and effective public health interventions to prevent serious disease and death. Because of the success of vaccines, most Americans today have no firsthand experience with such devastating illnesses as polio or diphtheria. Health care providers who vaccinate young children follow a schedule prepared by the U.S. Advisory Committee on Immunization Practices. Under the current schedule, children younger than six may receive as many as 24 immunizations by their second birthday. New vaccines undergo rigorous testing prior to receiving FDA approval; however, like all medicines and medical interventions, vaccines carry some risk.

Driven largely by concerns about potential side effects, there has been a shift in some parents' attitudes toward the child immunization schedule. The Childhood Immunization Schedule and Safety identifies research approaches, methodologies, and study designs that could address questions about the safety of the current schedule.

This report is the most comprehensive examination of the immunization schedule to date. The IOM authoring committee uncovered no evidence of major safety concerns associated with adherence to the childhood immunization schedule. Should signals arise that there may be need for investigation, however, the report offers a framework for conducting safety research using existing or new data collection systems.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!